ReviewInternational journal of environmental research and public health2018
Asbestos-Related Disorders in Germany: Background, Politics, Incidence, Diagnostics and Compensation.
Review in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Brazilian Thoracic Society recommendations for the diagnosis and monitoring of asbestos-exposed individuals.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024Guideline
- An Evaluation of Mortality Rates and Their Determinants in a Cohort of Former Asbestos Miners in South Africa.American journal of industrial medicine · 2026Article
- The notebook of personal health record system in Japan: framework of post-retirement health checkups for those formerly employed in hazardous occupations.Environmental and occupational health practice · 2026Article
- Latency Period Among Asbestosis Cases in South Korea by Demographic and Asbestos Exposure Characteristics.Toxics · 2025Article
- Cumulative asbestos exposure as a key predictor of long-term pleuropulmonary outcomes: insights from decades of follow-up.International archives of occupational and environmental health · 2025Article
- Challenges in Identifying and Diagnosing Asbestos-Related Diseases in Emerging Economies: A Global Health Perspective.Annals of global health · 2025Review
- Asbestos and disease - a public health success story?Scandinavian journal of work, environment & health · 2024Review
- Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Innovative surgical sciences · 2024Review
- Lung Cancer Screening in Asbestos-Exposed Populations.International journal of environmental research and public health · 2022Review
- Comparison of Asbestos Victim Relief Available Outside of Conventional Occupational Compensation Schemes.International journal of environmental research and public health · 2021Article
- Ongoing downplaying of the carcinogenicity of chrysotile asbestos by vested interests.Journal of occupational medicine and toxicology (London, England) · 2021Article
- Environmental and Occupational Exposure to Asbestos as a Result of Consumption and Use in Poland.International journal of environmental research and public health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There was some limited use of asbestos at end of the 19th century in industrialized countries including Germany, but its consumption dramatically increased after World War II. The increase in use and exposure was followed by the discovery of high numbers of asbestos-related diseases with a mean latency period of about 38 years in Germany. The strong socio-political pressure from the asbestos industry, its affiliated scientists and physicians has successfully hindered regulatory measures and an asbestos ban for many years; a restrictive stance that is still being unravelled in compensation litigation. This national experience is compared with the situation in other industrialized countries and against the backdrop of the constant efforts of the WHO to eliminate asbestos-related diseases worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.